Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Efficacy, Tolerability and Safety of CD4-Specific T-cell Vaccine in HIV Infection

NCT00407836 is registered in ClinicalTrials.gov with Soroka University Medical Center as lead sponsor.

NCT NCT00407836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00407836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Efficacy, Tolerability and Safety of CD4-Specific T-cell Vaccine in HIV Infection
Lead sponsor
Soroka University Medical Center
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2006
Completion date
November 30, 2008
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections